Fangjun Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 7
- Oncology 13
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Baorui Liu (19 shared papers)Fanyan Meng (14 shared papers)Zhengyun Zou (12 shared papers)Shu Su (10 shared papers)Juan Du (11 shared papers)Jie Shao (9 shared papers)Huizi Sha (7 shared papers)Jia Wei (11 shared papers)
- Journals
- Cellular Immunology (3 papers)Journal of Clinical Oncology (2 papers)International Immunopharmacology (1 paper)Genomics (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fangjun Chen
34 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 273
- Oncology 492
- Immunology 395
- Business and International Management 28
- Molecular Biology 665
Countries citing papers authored by Fangjun Chen
This map shows the geographic impact of Fangjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjun Chen more than expected).
Fields of papers citing papers by Fangjun Chen
This network shows the impact of papers produced by Fangjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjun Chen. The network helps show where Fangjun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 267 | |
| 2 | 2019 | 176 | |
| 3 | 2014 | 99 | |
| 4 | 2019 | 96 | |
| 5 | 2016 | 83 | |
| 6 | 2018 | 80 | |
| 7 | 2013 | 77 | |
| 8 | 2017 | 54 | |
| 9 | 2019 | 46 | |
| 10 | 2017 | 44 | |
| 11 | 2017 | 34 | |
| 12 | 2018 | 32 | |
| 13 | 2017 | 25 | |
| 14 | 2022 | 23 | |
| 15 | 2018 | 17 | |
| 16 | 2018 | 17 | |
| 17 | 2016 | 11 | |
| 18 | 2019 | 11 | |
| 19 | Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer. | 2018 | 11 |
| 20 | 2021 | 10 |
About Fangjun Chen
Fangjun Chen is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Genomics and Diagnostics (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (273 citations), Oncology (492 citations), Immunology (395 citations), Business and International Management (28 citations) and Molecular Biology (665 citations). Fangjun Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Baorui Liu, Fanyan Meng, Zhengyun Zou, Shu Su, Juan Du, Jie Shao, Huizi Sha, Jia Wei, Naiqing Ding and Lixia Yu. Their work appears in journals such as Cellular Immunology, Journal of Clinical Oncology, International Immunopharmacology, Genomics and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.